BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 23174735)

  • 21. Gallbladder metastasis from malignant melanoma: diagnosis with FDG PET/CT.
    Rehani B; Strohmeyer P; Jacobs M; Mantil J
    Clin Nucl Med; 2006 Dec; 31(12):812-3. PubMed ID: 17117082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunophenotyping of amelanotic melanoma. A case report.
    Lazarević V; Tiodorović J; Tiodorović-Zivković D; Stanojević M; Popović D; Janković A
    Acta Dermatovenerol Alp Pannonica Adriat; 2006 Sep; 15(3):141-3. PubMed ID: 17053850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amelanotic melanoma--"to be or not to be".
    Ladoyanni E; Abdullah A; Sterne GD; Zaki I
    Acta Derm Venereol; 2006; 86(2):189-90. PubMed ID: 16648938
    [No Abstract]   [Full Text] [Related]  

  • 24. Polypoid amelanotic melanoma: a diagnostic challenge.
    Milani-Nejad N; Scarbrough C; Mauzo SH; Peters SB; Bechtel MA; Carr D
    Dermatol Online J; 2018 Aug; 24(8):. PubMed ID: 30677854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hibernoma: 18F FDG PET/CT imaging.
    Subramaniam RM; Clayton AC; Karantanis D; Collins DA
    J Thorac Oncol; 2007 Jun; 2(6):569-70. PubMed ID: 17545854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ability of FDG-PET/CT in the detection of gallbladder cancer.
    Ramos-Font C; Gómez-Rio M; Rodríguez-Fernández A; Jiménez-Heffernan A; Sánchez Sánchez R; Llamas-Elvira JM
    J Surg Oncol; 2014 Mar; 109(3):218-24. PubMed ID: 24165875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In situ amelanotic melanoma of the nail unit mimicking lichen planus: report of 3 cases.
    André J; Moulonguet I; Goettmann-Bonvallot S
    Arch Dermatol; 2010 Apr; 146(4):418-21. PubMed ID: 20404232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of positron emission tomography by using F-18-fluorodeoxyglucose in diagnosis of recurrent colorectal cancer].
    Kula Z; Szefer J; Zuchora Z; Romanowicz G; Pietrzak T
    Pol Merkur Lekarski; 2004; 17 Suppl 1():63-6. PubMed ID: 15603351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) for the detection of skeletal muscle and skin metastases in uterine leiomyosarcoma: a case report.
    Ozdemir E; Poyraz NY; Uzun B; Türkölmez S
    Rev Esp Med Nucl Imagen Mol; 2013; 32(4):257-9. PubMed ID: 23153988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amelanotic melanoma: the great masquerader.
    Koch SE; Lange JR
    J Am Acad Dermatol; 2000 May; 42(5 Pt 1):731-4. PubMed ID: 10775846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of clinically amelanotic malignant melanoma and assessment of its margins by in vivo confocal scanning laser microscopy.
    Busam KJ; Hester K; Charles C; Sachs DL; Antonescu CR; Gonzalez S; Halpern AC
    Arch Dermatol; 2001 Jul; 137(7):923-9. PubMed ID: 11453812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Therapy of amelanotic melanoma].
    Blum A
    Dtsch Med Wochenschr; 2005 May; 130(20):1277. PubMed ID: 15889328
    [No Abstract]   [Full Text] [Related]  

  • 34. The role of positron emission tomography with computed tomography in the follow-up of asymptomatic cutaneous malignant melanoma patients with a high risk of disease recurrence.
    Abbott RA; Acland KM; Harries M; O'Doherty M
    Melanoma Res; 2011 Oct; 21(5):446-9. PubMed ID: 21849913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebriform nodular amelanotic metastases of malignant melanoma: a challenge in differential diagnosis of a rare variant.
    Assmann A; Farthmann B; Burkhardt O; Dippel E; Orfanos CE; Blume-Peytavi U
    Br J Dermatol; 2000 Mar; 142(3):533-6. PubMed ID: 10735966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
    Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S
    BJU Int; 2013 Oct; 112(6):729-34. PubMed ID: 23790129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amelanotic melanoma presenting as contact dermatitis.
    Aksu Çerman A; Demirçay Z; Demirkesen C
    Eur J Dermatol; 2010; 20(6):857-8. PubMed ID: 20956099
    [No Abstract]   [Full Text] [Related]  

  • 38. External ultrasonography of the neck does not add diagnostic value to integrated positron emission tomography-computed tomography (PET-CT) scanning in the diagnosis of cervical lymph node metastases in patients with esophageal carcinoma.
    Blom RL; Vliegen RF; Schreurs WM; Belgers HJ; Stohr I; Oostenbrug LE; Sosef MN
    Dis Esophagus; 2012 Aug; 25(6):555-9. PubMed ID: 22150869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral amelanotic malignant melanoma: a case report.
    Aziz Z; Aboulouidad S; Bouihi ME; Hattab NM; Chehbouni M; Raji A
    Pan Afr Med J; 2020; 37():350. PubMed ID: 33738038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinically and dermoscopically featureless melanoma: when prevention fails.
    Carli P; Massi D; de Giorgi V; Giannotti B
    J Am Acad Dermatol; 2002 Jun; 46(6):957-9. PubMed ID: 12063500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.